Around a quarter of heart patients who undergo percutaneous coronary intervention (PCI) are readmitted to the hospital for unplanned reasons within six months of their procedure, researchers report in JACC: Cardiovascular Interventions.
The global wearable medical devices market is expected to surpass $29 billion by 2026, according to a report from Transparency Market Research (TMR), expanding at a projected compound annual growth rate (CAGR) of more than 17% over the next seven years.
The FDA’s Circulatory System Devices Panel of the Medical Devices Advisory Committee will meet in mid-June to discuss recent controversies and safety practices surrounding paclitaxel-coated and -eluting medical devices, according to a notice posted April 22.
Boston Scientific’s LOTUS Edge Aortic Valve System was cleared by the FDA April 23 for use in high-risk surgical candidates with severe aortic stenosis.
The CDC’s most recent Health, United States report, released this April, reveals the extent to which racial and ethnic disparities in the U.S. affect cardiovascular care and rates of heart disease in the country.
A study of nearly 4,000 patients with coronary artery disease (CAD) has linked blood pressure variability (BPV) between clinic visits to significantly greater progression of coronary atheroma and major adverse events, suggesting BP stability might be an important factor in CAD care.
The cardiology division at Columbia University’s Vagelos College of Physicians and Surgeons received a donation of $32.5 million this month—a gift the program’s leaders say will go toward patient care, research and education.
Pharmacy closures across the U.S. are driving significant declines in medication adherence among Americans, a recent study has found, especially those who are older and live in neighborhoods with low accessibility.
A cardiologist at St. Joseph’s Hospital in Syracuse, N.Y., is one of 60 that’s been charged in an illegal prescription opioid scandal that spans the U.S.
The American Academy of Pediatrics’ (AAP) updated blood pressure guidelines classify more kids in higher BP categories and can more accurately predict which children are prone to heart disease later in life, an extensive analysis of the Bogalusa Heart Study has found.
